3-cyano-7-ethoxycoumarin has been researched along with ticlopidine in 1 studies
| Studies (3-cyano-7-ethoxycoumarin) | Trials (3-cyano-7-ethoxycoumarin) | Recent Studies (post-2010) (3-cyano-7-ethoxycoumarin) | Studies (ticlopidine) | Trials (ticlopidine) | Recent Studies (post-2010) (ticlopidine) |
|---|---|---|---|---|---|
| 6 | 0 | 3 | 10,289 | 1,893 | 4,671 |
| Protein | Taxonomy | 3-cyano-7-ethoxycoumarin (IC50) | ticlopidine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.382 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 6.2928 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.304 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.175 | |
| Cytochrome P450 2B6 | Homo sapiens (human) | 0.405 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.6678 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.426 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, KC; Li, L; Li, YX; Wang, JF; Wei, DQ; Zheng, SY | 1 |
1 other study(ies) available for 3-cyano-7-ethoxycoumarin and ticlopidine
| Article | Year |
|---|---|
3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design.
Topics: Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2C19; Drug Design; Fatty Acids, Monounsaturated; Fluvastatin; Fluvoxamine; Indoles; Ligands; Mixed Function Oxygenases; Models, Molecular; Nitriles; Protein Conformation; Structure-Activity Relationship; Ticlopidine | 2007 |